怀孕期间的C型肝炎治疗:实践改变的时间
Karley Dutra1, Jonathan M Fenkel2
1Thomas Jefferson University Hospital, Department of Obstetrics and Gynecology.
American journal of obstetrics & gynecology MFM
|December 9, 2025
概括
在怀孕期间,使用直接作用抗病毒药物 (DAA) 可以安全有效地治疗C型肝炎病毒 (HCV) 感染. 这种方法为防止围产期传播和改善婴儿结果提供了关键的机会.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 产科 产科 产科 产科 产科
- 传染性疾病 传染性疾病
背景情况:
- 型肝炎病毒 (HCV) 感染对公众健康构成重大挑战,特别是在生育年龄的人群中.
- 目前的产科指南不建议在怀孕期间治疗HCV,因为直接作用抗病毒药物的安全性和有效性数据有限.
- 周产期HCV传播风险高达9%,暴露后婴儿随访率较低.
研究的目的:
- 评估DAA在怀孕期间治疗HCV感染的安全性和有效性.
- 为了突出怀孕作为一个最佳的窗口对HCV治疗,由于持续的患者参与护理.
- 为妇产科医生提供有关怀孕女性HCV治疗的共享决策的信息.
主要方法:
- 关于在怀孕期间使用DAA的最新证据的审查.
- 对孕妇与非孕妇成年人治愈率的分析.
- 对第二和第三季度以及通过母乳暴露的DAA暴露数据的评估.
主要成果:
- 越来越多的证据表明,DAA在怀孕期间对HCV治疗是安全和有效的,治愈率与非怀孕的成年人相似.
- 关于通过母乳接触DAA的数据有限但令人放心.
- 莱迪帕斯维尔/索福斯布维尔和索福斯布维尔/韦尔帕斯维尔是怀孕治疗最多的可用数据.
结论:
- 怀孕期间的HCV治疗是可行的,并建议,最好是在第二或第三个三个月开始.
- 共享决策至关重要,平衡治疗效益与DAA暴露数据.
- 多学科合作对于优化孕妇获得HCV治疗的机会至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Standard Precaution
2.7K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Transmission-based Precautions I: Contact, Enteric, and Droplets
4.5K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.5K


